These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7572049)

  • 1. Primary systemic amyloidosis presenting with polyneuropathy characterized by very long survival.
    Rinaldi R; Azzimondi G; Preda P; Ricci P; D'Alessandro R; Pazzaglia P
    Acta Neurol Scand; 1995 Jun; 91(6):511-3. PubMed ID: 7572049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic amyloidosis with initial polyneuropathy.
    Lee DD; Huang CY; Wong CK; Kao KP
    J Dermatol; 1996 Apr; 23(4):296-8. PubMed ID: 8935350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical presentations of primary amyloid neuropathy.
    Vucic S; Chong PS; Cros D
    Muscle Nerve; 2003 Dec; 28(6):696-702. PubMed ID: 14639583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary systemic amyloidosis presenting with asymmetric multiple mononeuropathies.
    Sadek I; Mauermann ML; Hayman SR; Spinner RJ; Gertz MA
    J Clin Oncol; 2010 Sep; 28(25):e429-32. PubMed ID: 20406934
    [No Abstract]   [Full Text] [Related]  

  • 5. Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Magy L; Diallo L; Boukhris S; Vallat JM
    Muscle Nerve; 2012 Jan; 45(1):26-31. PubMed ID: 22190302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome].
    Adams D; Lozeron P; Theaudin M; Ribrag V; Bourhis JH; Lacroix C
    Rev Neurol (Paris); 2011 Jan; 167(1):57-63. PubMed ID: 21190703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary localized cutaneous nodular amyloidosis successfully treated with cyclophosphamide.
    Tong PL; Walker WA; Glancy RJ; Cooney JP; Gebauer K
    Australas J Dermatol; 2013 Feb; 54(1):e12-5. PubMed ID: 23373889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teaching neuroimages: dyspnea as a presenting manifestation of amyloid myopathy.
    Ghosh PS; Thaera GM; Tracy JA
    Neurology; 2013 Dec; 81(24):e184. PubMed ID: 24323446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
    Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
    Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy.
    Rajkumar SV; Gertz MA; Kyle RA
    Am J Med; 1998 Mar; 104(3):232-7. PubMed ID: 9552085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polyneuropathy associated with monoclonal gammopathy of undetermined significance].
    Moth Henriksen M; Kolmos EB; Abildgaard N; Schrøder HD; Sindrup S
    Ugeskr Laeger; 2012 Oct; 174(43):2630-4. PubMed ID: 23095652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyneuropathy with monoclonal gammopathy: studies of 11 patients.
    Dalakas MC; Engel WK
    Ann Neurol; 1981 Jul; 10(1):45-52. PubMed ID: 6267981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of immune suppression in systemic diseases affecting the kidney].
    Ballarín J; Díaz M
    Nefrologia; 2008; 28 Suppl 5():91-6. PubMed ID: 18847427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance.
    Simmons Z; Bromberg MB; Feldman EL; Blaivas M
    Muscle Nerve; 1993 Jan; 16(1):77-83. PubMed ID: 8380902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study.
    Kikukawa Y; Yuki H; Hirata S; Ide K; Nakata H; Miyakawa T; Matsuno N; Nosaka K; Yonemura Y; Kawaguchi T; Hata H; Mitsuya H; Okuno Y
    Int J Hematol; 2015 Feb; 101(2):133-9. PubMed ID: 25430082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary amyloid polyneuropathy-related destructive arthropathy in a hip joint.
    Sato S; Seki H; Ikeda SI
    Amyloid; 2017 Mar; 24(1):64-65. PubMed ID: 28393569
    [No Abstract]   [Full Text] [Related]  

  • 17. Scleroderma-like manifestation in a patient with primary systemic amyloidosis: response to high-dose intravenous immunoglobulin and plasma exchange.
    Cho SB; Park JS; Kim HO; Chung KY
    Yonsei Med J; 2006 Oct; 47(5):737-40. PubMed ID: 17066519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroneurophysiological studies in familial amyloid polyneuropathy--Portuguese type.
    Luís ML
    J Neurol Neurosurg Psychiatry; 1978 Sep; 41(9):847-50. PubMed ID: 690658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long standing polyneuropathy as a form of presentation of primary systemic amyloidosis.
    Jiménez Caballero PE
    Neurologia; 2012 Sep; 27(7):447-8. PubMed ID: 22217524
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary systemic amyloidosis. Early diagnosis and therapy can improve survival rates and quality of life.
    Roy A; Roy V
    Postgrad Med; 2006; 119(1):93-9. PubMed ID: 16913652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.